Legal & General Group PLC Instil Bio, Inc. Transaction History

Legal & General Group PLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$4.65 - $7.37 $4,473 - $7,089	962 Added 16.4%	6,828 $33,000
Q2 2022 Aug 22, 2022	BUY	$4.21 - $11.15 $538 - $1,427	128 Added 2.23%	5,866 $27,000
Q4 2021 Feb 14, 2022	BUY	$15.37 - $22.5 $51,535 - $75,442	3,353 Added 140.59%	5,738 $98,000
Q2 2021 Aug 12, 2021	BUY	$15.31 - $24.63 $28,859 - $46,427	1,885 Added 377.0%	2,385 $46,000
Q1 2021 May 17, 2021	BUY	$24.23 - $27.06 $12,115 - $13,530	500 New	500 $13,000

1.9M

Ticker TIL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 129,694,000
Market Cap $2.67B
Description
Instil Bio, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of patients with cancer. The company develops cell therapy of autologous tumor infiltrating lymphocyte (TIL). Its TIL product candidates in pipeline include ITIL-168 for indications, such as melanoma, cutaneous squamous cell carcinoma, non-small ce...

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

Stay updated on Legal & General Group PLC with notifications on news.